Featured Topics
Calendar

August 04, 2026

Q2 2026 Results / Half-Year Financial Report
Q2 2026 Media Update

September 02, 2026

Bayer Crop Science Investor Event
Press Releases
Share Price / Index
June 17, 2026
Not intended for UK Media
Bayer completes acquisition of Perfuse Therapeutics
June 15, 2026
Bayer’s low-dose MRI contrast agent approved in U.S.
June 10, 2026
European Medicines Agency confirms Bayer’s FXIa inhibitor marketing authorization application for assessment in secondary prevention of ischemic stroke

Our Products

Our broad product portfolio includes many world-famous brands that have shaped our Bayer brand. With our products, we are helping to find solutions to some of the greatest challenges of our time. So that health and nutrition can be made available to everyone.